| Johnson & Johnson (JNJ),
a diversified health care products company, has an impressive 10-year
price upside. The maker of Band-Aids and Tylenol has three major
divisions: pharmaceuticals, consumer products and medical devices.
JNJ has increased its sales for 73 consecutive years and its dividend
for 44 consecutive years. It pays a $1.50 dividend for a 2.30 percent
dividend yield as of December 29, 2006. JNJ is a great stock for
a dividend reinvestment portfolio.
JNJ is included in the
buyupside.com high performers portfolio and the buyupside.com
core stock portfolio, which contains dividend-paying stocks
and two exchange traded funds (ETFs).
Click on the blue chart to the right to see more information about Johnson
& Johnson.
Related Articles:
Emerson Electric Is a Stock to Own
for the Long Run
Wrigley Is a Winner
Posted January 7, 2007.
|
|
